← FDA Drug Approvals (Drugs@FDA)

ALHEMO

BLA · Biologics License Application · Sponsor: NOVO NORDISK INC · Approved 2024-12-20

Drug application

FDA Application #

BLA761315

Application type

Biologics License Application

Brand name

ALHEMO

Generic name

CONCIZUMAB

Active ingredients

CONCIZUMAB-MTCI

Dosage form

Injectable

Route

Subcutaneous

Marketing status

Prescription

Sponsor

NOVO NORDISK INC

Manufacturer

Novo Nordisk

First approval

2024-12-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown